Alexander Rosén Files SC 13D for Jupiter Neurosciences

TL;DR

**ROSEN BUYS JUPITER NEUROSCIENCES STOCK - 13D FILED**

AI Summary

On November 8, 2024, Alexander Rosén filed a Schedule 13D for Jupiter Neurosciences, Inc. This filing indicates a change in beneficial ownership of the company's common stock. Rosén's address is listed as 1001 North US HWY 1, Suite 504, Jupiter, Florida.

Why It Matters

This filing signals a potential shift in control or significant stake-building by Alexander Rosén in Jupiter Neurosciences, Inc., which could impact the company's stock price and strategic direction.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant stake accumulation or changes in control, which can lead to increased volatility and uncertainty for investors.

Key Players & Entities

• Jupiter Neurosciences, Inc. (company) — Subject Company
• Alexander Rosén (person) — Filing Person
• Rosen Alexander Gustaf Erik (person) — Filing Person
• Jupiter Orphan Therapeutics, Inc. (company) — Former Company Name

FAQ

From the Filing

0001493152-24-046384.txt : 20241115 0001493152-24-046384.hdr.sgml : 20241115 20241115214447 ACCESSION NUMBER: 0001493152-24-046384 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20241115 DATE AS OF CHANGE: 20241115 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: JUPITER NEUROSCIENCES, INC. CENTRAL INDEX KEY: 0001679628 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474828381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-94749 FILM NUMBER: 241469602 BUSINESS ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 BUSINESS PHONE: (561) 406-6154 MAIL ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 FORMER COMPANY: FORMER CONFORMED NAME: Jupiter Orphan Therapeutics, Inc. DATE OF NAME CHANGE: 20160713 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Rosen Alexander Gustaf Erik CENTRAL INDEX KEY: 0001892458 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13D MAIL ADDRESS: STREET 1: 219 NEW HAVEN BLVD CITY: JUPITER STATE: FL ZIP: 33458 SC 13D 1 formsc13d.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Jupiter Neurosciences, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 48208B203 (CUSIP Number) Alexander Rosén 1001 North US HWY 1, Suite 504 Jupiter, Florida 33477 Phone: (561) 406-6154 (Name, Address, and Telephone Number of Person Authorized to Receive Notices and Communications) November 8, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐ Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 48208B203 1 NAMES OF REPORTING PERSON Alexander Rosén 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐ 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) OO 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E) ☐ 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 1,789,100 * 8 SHARED VOTING POWER 0 9 SOLE DISPOSITIVE POWER 1,789,100 * 10 SHARED DISPOSITIVE POWER 0 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,789,100 * 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.7% ** 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN * Represents (i) 356,250 shares of Issuer’s common stock (“common stock”), (ii) 1,171,688 shares of common stock issuable upon exercise of stock options, (iii) 96,608 shares of common stock pursuant to a restricted stock award grant, and (iv) 164,554 shares of common stock pursuant to a restri